Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.

Expert review of molecular diagnostics - 1 Nov 2013

Marzese Diego M, Hirose Hajime, Hoon Dave S B

Abstract excerpt

Qualitative and quantitative analysis of circulating cell-free DNA (cfDNA) is an emerging non-invasive blood biomarker utilized to assess tumor progression and to evaluate prognosis, diagnosis and response to treatment. There is a need to develop cfDNA biomarkers to avoid complex risk-prone biopsy procedures for primary or metastatic tumors. Given the challenges associated with inter- and intra-tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cancer Genomics and Diagnostics
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Early Detection of Cancer

Share to Mutation

Share to Predictive Value of Tests

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 24127721
DOI: 10.1586/14737159.2013.845088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.PMID 24127721Read ↗

Detection of Circulating Tumor DNA in Plasma Using Targeted Sequencing.Semantic proximity Read ↗

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Semantic proximity Read ↗

The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasisSemantic proximity Read ↗

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer ManagementSemantic proximity Read ↗

Circulating free DNA in the era of precision oncology: Pre‐ and post‐analytical concernsSemantic proximity Read ↗

Strategies for improving detection of circulating tumor DNA using next generation sequencing.Semantic proximity Read ↗

Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer PatientsSemantic proximity Read ↗

Clinical application of circulating tumor DNA in metastatic cancers.Semantic proximity Read ↗

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.Semantic proximity Read ↗

Circulating Cell-Free DNA—Diagnostic and Prognostic Applications in Personalized Cancer TherapySemantic proximity Read ↗

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatmentSemantic proximity Read ↗

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoringSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.